tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB

Matinas BioPharma (MTNB) Stock Investors

1,434 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MTNB
On average, investors allocate 0.00% of their portfolios to MTNB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,786 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MTNB

0.7%
Last 7
Days
1.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MTNB, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MTNB Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$0.28
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in MTNB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MTNB Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.19%
-1.26%
-3.57%
37.89B
Consumer Cyclical
GE Aerospace
5.53%
+1.08%
+6.09%
168.04B
Industrials
Plug Power
4.90%
-0.92%
-6.51%
1.95B
Industrials
ChargePoint Holdings
3.92%
-0.91%
-7.35%
668.91M
Consumer Cyclical
Riot Platforms
4.74%
-1.51%
+0.37%
2.17B
Financial
AMC Entertainment
5.42%
-1.38%
-6.90%
651.10M
Communication Services
Marathon Digital Holdings
5.39%
-0.26%
-3.45%
4.28B
Financial
Blink Charging Co
5.07%
-1.37%
-6.36%
231.28M
Industrials
XPeng, Inc. ADR
5.22%
-1.15%
-5.51%
7.04B
Consumer Cyclical
Li Auto
5.53%
-0.82%
-4.51%
29.46B
Consumer Cyclical
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

MTNB Investor Analysis

MTNB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.2%
of MTNB holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
MTNB investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.9%
of MTNB holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
MTNB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
27.8%
of MTNB holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of MTNB stock investors
See who invests in MTNB according to age group and performance.

FAQ

How many retail Investors hold MTNB?
<0.1% of TipRanks' retail investors hold MTNB in their portfolios.
    What is MTNB Investor Sentiment?
    MTNB’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of MTNB in the last 7 days?
      ▲ 0.7% of TipRanks' retail investors changed their holding of MTNB in the last 7 days.
        What percentage of retail investors changed their holding of MTNB in the last 30 days?
        ▼ 1.0% of TipRanks' retail investors changed their holding of MTNB in the last 30 days.
          What is the average age of retail investors who hold MTNB?
          The average age of MTNB Holders is between 35–55.
            What other stocks have MTNB investors also bought?
            MTNB Investors also bought DKNG, GE, PLUG, CHPT, RIOT, AMC, MARA, BLNK, XPEV, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis